XXXXXXXXX XXXXXXXXXX KOMISE (XX) 2020/528
xx xxx 14. xxxxx 2020,
xxxxxx xx xxxxxxxxx xxxxxxxxxx x Brazílii, Číně, Xxxxx Xxxxxx, Xxxxxxxxx xxxxxxx x Thajsku xx xxxxxx xxxxxxxxx xxxxxxxxxxxxx testů xxx xxxxxxxxx xxxxxxxxx očkovacích xxxxx xxxxx xxxxxxxxx x psů, xxxxx x xxxxxx
(xxxxxxxx pod xxxxxx C(2020) 2103)
(Xxxx x xxxxxxxx xxx XXX)
XXXXXXXX XXXXXX,
x xxxxxxx xx Xxxxxxx x xxxxxxxxx Xxxxxxxx xxxx,
x xxxxxxx xx xxxxxxxxxx Rady 2000/258/ES xx xxx 20. xxxxxx 2000 o xxxxxx xxxxxxxxxx institutu xxxxxxxxxxx xx stanovení xxxxxxxx xxxxxxxxxx pro xxxxxxxxxxx xxxxxxxxxxxxx xxxxx xxx sledování xxxxxxxxx xxxxxxxxxx látek xxxxx xxxxxxxxx&xxxx;(1), x zejména xx xx. 3 xxxx. 2 uvedeného xxxxxxxxxx,
xxxxxxxx k xxxxx xxxxxxx:
|
(1) |
Xxxxxxxxxx 2000/258/XX xxxxxx xxxxxxxxx Xxxxxx xxxxçxxxx xx xxxxxxxx sanitaire xxx xxxxxxxx (xxxx xxx „AFSSA“) ve xxxxxxxxxxxx Xxxxx jako xxxxxxxx institut xxxxxxxxx xx stanovení xxxxxxxx xxxxxxxxxx xxx xxxxxxxxxxx xxxxxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxx xxxxx xxxxxxxxx. XXXXX xxxx xxxx xxxxxxxxx do Agence xxxxxxxxx xx xxxxxxxx xxxxxxxxx xx x’xxxxxxxxxxxx, xx x’xxxxxxxxxxxxx xx xx travail (dále xxx „XXXXX“) xx Xxxxxxx. |
|
(2) |
Xxxxxxxxxx 2000/258/XX xxxx xxxx stanoví, že XXXXX xxxxxxx xxxxxxxxxx xx třetích zemích, xxxxx xxxxxxxxxx žádost x xxxxxxxxx xx xxxxxx xxxxxxxxx sérologických xxxxx xxx xxxxxxxxx xxxxxxxxx xxxxxxxxxx látek xxxxx xxxxxxxxx. |
|
(3) |
Xxxxxxxxx xxxxx x Xxxxxxxx xxxxxxxxx xxxxxx o xxxxxxxxx xxxxxxxxxx „Xxxxxx xx Xxxxxxxxx em Xxxxx xx Laboratório xx Xxxxxxxxx Xxxxxxx e Xxxxxxxxx do Xxxxxxxxx xx Xxêxxxxx Biomédicas xx Universidade de Xãx Xxxxx“. ANSES xxx xxxx xxxxxxxxx xxxxxxxxxxx xxxxxxxxx hodnotící xxxxxx ze xxx 24. xxxxx 2019, xxxxxx xxxxxxxxxx Xxxxxx. |
|
(4) |
Xxxxxxxxx xxxxx Xxxx xxxxxxxxx xxxxxx o xxxxxxxxx xxxx xxxxxxxxxx: „Sino Xxxx World Xxxxxxxxxxx Xxxxxxxxxxxxxx Xx., Ltd (Xxxxxx)“ a „Animal Xxxxxxx Diagnostic Center xx xxx Institute xx Xxxxxx Xxxxxx xx the Xxxxxxxxx Xxxxxxx xx Xxxxxxxxxxx Xxxxxxxx“. XXXXX xxx xxxx laboratoře xxxxxxxxxxx xxxxxxxxx hodnotící xxxxxx xx xxx 24. xxxxx 2019, kterou xxxxxxxxxx Xxxxxx. |
|
(5) |
Xxxxxxxxx orgán Xxxx xxxxxxxxx xxxxxx x xxxxxxxx xxxxxxxxx xxxx xxxxxxxxxx: „Xxxxxxxx Xxxxxxxxx Laboratory for Xxxxxx Xxxxxx (Diagnostic Xxxxxxxxxx for Xxxxxx xxx Xxxxxxxx Xxxxxxxxxx Xxxxxxxx)“ a „Centre xxx Xxxxxx Antibody Xxxxx of xxx Xxxxxxxxxx xx Xxxxxxxxxxxx xx xxx Military Xxxxxxxxxx Research Institute xx the Academy xx Xxxxxxxx Xxxxxxx Xxxxxxxx“. XXXXX xxx xxxx xxxxxxxxxx vypracovala xxxxxxxxx xxxxxxxxx zprávu xx xxx 24. xxxxx 2019, xxxxxx xxxxxxxxxx Komisi. |
|
(6) |
Příslušný xxxxx Xxxxx Koreje xxxxxxxxx xxxxxx x xxxxxxxxx xxxxxxxxxx „Rabies xxx Xxxxxxxx xxxxxxxxxxxx XXX xxxxxxxxx xxxxxxxxxx of Xxxxxx xxx Xxxxx Xxxxxxxxxx Agency“. XXXXX xxx xxxx xxxxxxxxx xxxxxxxxxxx xxxxxxxxx hodnotící xxxxxx ze dne 24. xxxxx 2019, xxxxxx xxxxxxxxxx Xxxxxx. |
|
(7) |
Xxxxxxxxx xxxxx Xxxxxxx xxxxxxxxx xxxxxx o schválení xxxxxxxxxx „Xxxxxxxx Xxxxxxxxx xx Xxxxxx Xxxxxx“. XXXXX pro xxxx xxxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx xxxxxx ze xxx 24. října 2019, xxxxxx xxxxxxxxxx Xxxxxx. |
|
(8) |
Xxxxxxxxx orgán Xxxxxxxxx xxxxx xxxxxxxxx žádost x xxxxxxxx schválení xxxxxxxxxx „Centers xxx Xxxxxxx Control xxx Xxxxxxxxxx xx xxx Xxxxxx Xxxxxxxxxx“. ANSES xxx xxxx xxxxxxxxx xxxxxxxxxxx xxxxxxxxx hodnotící xxxxxx xx xxx 24. října 2019, xxxxxx předložila Xxxxxx. |
|
(9) |
Xxxx xxxxxxxxxx by proto xxxx xxx xxxxxxxxx xx xxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxx pro xxxxxxxxx účinnosti xxxxxxxxxx xxxxx xxxxx vzteklině x xxx, xxxxx x xxxxxx. |
|
(10) |
Xxxxxxxx stanovená xxxxx xxxxxxxxxxx jsou x xxxxxxx xx xxxxxxxxxxx Stálého xxxxxx xxx xxxxxxxx, xxxxxxx, xxxxxxxxx x xxxxxx, |
XXXXXXX XXXX ROZHODNUTÍ:
Xxxxxx 1
X xxxxxxx x čl. 3 xxxx. 2 xxxxxxxxxx 2000/258/XX xx xxx xxxxxxxxx xxxxxxxxxxxxx xxxxx xx xxxxxx sledování xxxxxxxxx očkovacích látek xxxxx xxxxxxxxx x xxx, xxxxx a xxxxxx xxxxxxxxx xxxx xxxxxxxxxx:
|
x) |
Xxxxxx de Pesquisas xx Xxxxx Xxxxxxxxxxx xx Xxxxxxxxx Xxxxxxx x Xxxxxxxxx xx Xxxxxxxxx xx Xxêxxxxx Xxxxxxxxxx Xxxxxxxxxxxx xx Xãx Xxxxx Xx. Xxxx. Xxxxx Xxxxxxx, 1374, xxxx 225 05508-000 Xãx Xxxxx Xxxxxxxx |
|
x) |
Xxxx Xxxx Xxxxx Biologicals Xxxxxxxxxxxxxx Xx., Ltd (Xxxxxxx) 29 Xxxxxxxx West Xxxx. Xxxxxxxxxx Medicine Base, Xxxxxx Xxxxxxxx, Xxxxxx Čína |
|
x) |
Xxxxxx Xxxxxxx Xxxxxxxxxx Center Xxxxxxxxx xx Xxxxxx Health, Guangdong Xxxxxxx of Xxxxxxxxxxx Xxxxxxxx 21 Xxxxxxxxxx Xxxxxx, Xxxxxx Xxxxxxxx Xxxxxxxxx, Xxxxxxxxx Xxxx |
|
x) |
Xxxxxxxx Xxxxxxxxx Laboratory for Xxxxxx Xxxxxx (Diagnostic Xxxxxxxxxx xxx Rabies xxx Xxxxxxxx Associated Xxxxxxxx) Xxxxxxxxx Xxxxxxxxxx Xxxxxxxx Xxxxxxxxx, Xxxxxxx Academy xx Xxxxxxxxxxxx Xxxxxxxx 666 Xxxxxxx Xxxx Xxxx, Xxxxxxx Economy Development Xxxxxxxx, Xxxxxxxxx, Xxxxx, Xxxx |
|
x) |
Xxxxxx xxx Xxxxxx Xxxxxxxx Xxxxx, Laboratory xx Xxxxxxxxxxxx, Xxxxxxxx Xxxxxxxxxx Xxxxxxxx Xxxxxxxxx, Academy xx Xxxxxxxx Xxxxxxx Xxxxxxxx 666 Xxxxxxx West Xxxx, Jingyue Xxxxxxx Xxxxxxxxxxx District Changchun, Xxxxx Xxxx |
|
f) |
Rabies xxx Japanese encephalitis XXX reference laboratory xx xxx Xxxxxx xxx Xxxxx Quarantine Xxxxxx 177 Xxxxxxxx 8-xx, Xxxxxxxx-xx, Xxxxxxxxxxxxx-xx, 39660, Xxxxx Xxxxx |
|
x) |
Xxxxxxx xxx Xxxxxxx Xxxxxxx xxx Xxxxxxxxxx Xxxxxx Xxxxxxxxxx 1600 Xxxxxxx Xxxx, XX, Xxxxxxx, XX 30333, Xxxxxxx státy americké |
|
h) |
Xxx Xxxxxxxx Institute xx Xxxxxx Xxxxxx 50/2 Xxxxxxxxxx, Xxxxxx, Xxxxxxxxx Xxxxxxx 10900 Thajsko |
Xxxxxx 2
Xxxx xxxxxxxxxx xx xxxxxx xxxxxxxx xxxxxx.
X Xxxxxxx dne 14. xxxxx 2020.
Za Xxxxxx
Xxxxxx XXXXXXXXXX
členka Xxxxxx
(1)&xxxx;&xxxx;Xx. věst. X 79, 30.3.2000, s. 40.